Curative Biosciences Inc
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 an… Read more
Market Cap & Net Worth: Curative Biosciences Inc (CBDX)
Curative Biosciences Inc (PINK:CBDX) has a market capitalization of $3.16K ($3.16K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #48430 globally and #14894 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Curative Biosciences Inc's stock price $0.00 by its total outstanding shares 31574695 (31.57 Million).
Curative Biosciences Inc Market Cap History: 2015 to 2025
Curative Biosciences Inc's market capitalization history from 2015 to 2025. Data shows change from $11.05 Million to $3.16K (-61.16% CAGR).
Curative Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Curative Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CBDX by Market Capitalization
Companies near Curative Biosciences Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Curative Biosciences Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Curative Biosciences Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Curative Biosciences Inc's market cap moved from $11.05 Million to $ 3.16K, with a yearly change of -61.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.16K | 0.00% |
| 2024 | $3.16K | -93.33% |
| 2023 | $47.36K | -28.57% |
| 2022 | $66.31K | +950.00% |
| 2021 | $6.31K | -99.87% |
| 2020 | $4.74 Million | -48.08% |
| 2019 | $9.12 Million | -3.70% |
| 2018 | $9.47 Million | -5.96% |
| 2017 | $10.07 Million | -27.50% |
| 2016 | $13.89 Million | +25.71% |
| 2015 | $11.05 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Curative Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.16K USD |
| MoneyControl | $3.16K USD |
| MarketWatch | $3.16K USD |
| marketcap.company | $3.16K USD |
| Reuters | $3.16K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.